TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Prosetta Biosciences Stock

Prosetta Biosciences Stock

prosetta.comHealthcareFounded: 2003Funding to Date: $63.64MM

Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).

Buy or sell Prosetta Biosciences stockLearn more about Prosetta Biosciences IPO
Register for Details

For more details on financing and valuation for Prosetta Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Prosetta Biosciences.

Register Today

Team

Management Team

Karl Manheim
Co-Founder & Board Member
Vishwanath Lingappa Ph.D
Co-Founder, Board Member, Chief Technology Officer & Chief Executive Officer
Thomas Higgins
Founding Chief Executive & Chairman

Board Members

CJ Sylvester
Fred Alger Management
Vishwanath Lingappa Ph.D
Dale Bredesen MD
Karl Manheim
Charles Parrish
David Keys
Thomas Higgins

Other companies like Prosetta Biosciences in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Paradromics
Sector
Healthcare
 
 
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B

News

PRNewswire 03/28/2017
Purch Expands Industry-Leading Yield Optimization Platform
NEW YORK, March 28, 2017 /PRNewswire/ -- Purch, a digital publishing and marketplace platform, announced today that...

Trending Companies

Frequently Asked Questions

Updated on: Jun 4, 2023